Location History:
- Aspinall, PA (US) (2010)
- Pittsburgh, PA (US) (2013 - 2015)
- Port St. Lucie, FL (US) (2015 - 2017)
- Athens, GA (US) (2017 - 2020)
Company Filing History:
Years Active: 2010-2020
Title: The Innovative Contributions of Ted M. Ross in Influenza Research
Introduction
Ted M. Ross is a notable inventor and researcher based in Athens, GA. He holds an impressive portfolio of 16 patents, primarily focusing on the development of broadly reactive antigens for various strains of the influenza virus. His cutting-edge work is instrumental in advancing vaccine development and immunological research.
Latest Patents
Two of Ted M. Ross's latest patents greatly contribute to our understanding and treatment of influenza. The first patent, titled "Computationally Optimized Broadly Reactive Antigens for Human and Avian H5N1 Influenza," describes the generation of optimized H5N1 influenza HA polypeptides. These polypeptides are specifically designed to elicit a broadly reactive immune response against H5N1 virus isolates. By conducting a series of HA protein alignments and generating consensus sequences based on human and avian H5N1 isolates, Ross has created optimized HA polypeptides, compositions, fusion proteins, and VLPs containing these polypeptides. Moreover, he has also developed codon-optimized nucleic acid sequences encoding the HA polypeptides along with methods to elicit an immune response against influenza in subjects.
The second patent focuses on H1N1 influenza, titled "Computationally Optimized Broadly Reactive Antigens for H1N1 Influenza." Similar to his work on H5N1, this invention involves the generation of optimized H1N1 HA polypeptides capable of inducing a broadly reactive immune response to various H1N1 virus isolates. By analyzing HA protein alignments and creating consensus sequences based on selected H1N1 viruses isolated from 1918 to 2011, Ross developed optimized HA polypeptides and corresponding materials to enhance immune responses.
Career Highlights
Ted M. Ross has made significant strides in the field of immunology while working at the University of Pittsburgh. His innovative approach to vaccine development, specifically in the domain of influenza research, has led to substantial advancements in preventive medicine. Not only has he contributed to the scientific community through his patents, but his work also holds the potential to impact public health on a global scale.
Collaborations
Throughout his career, Ted M. Ross has collaborated with talented individuals like Corey J. Crevar and Brendan M. Giles. These partnerships have fostered an environment of innovation and allowed for the blending of ideas and expertise, further enhancing the scope and impact of their research.
Conclusion
Ted M. Ross stands out as a key inventor in the field of influenza research, with his patents demonstrating a commitment to advancing vaccine technologies. His contributions not only highlight the importance of collaborative efforts in scientific research but also pave the way for future innovations in immunology. With a strong foundation of patents and ongoing research, Ross continues to leave a significant mark in the healthcare industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.